Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/38757
Title: | SEOM clinical guideline in nasopharynx cancer (2017). | |
Authors: | ||
Keywords: | ||
Mesh: | ||
Issue Date: | Jan-2018 | |
Citation: | Clin Transl Oncol.2018 Jan;(20)1:84-88 | |
Abstract: | Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time. | |
PMID: | 29098554 | |
URI: | https://hdl.handle.net/20.500.12530/38757 | |
Rights: | openAccess | |
Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos | |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PMC5785612.pdf | 347.47 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.